Speeches Shim
Last updated: January 10, 2022
As of December 2021, the U.S. Government has allocated more than $75.5 million in new resources and two million doses of Pfizer-BioNTech vaccines to assist Peru in its emergency response to COVID-19. The aid continues a strong history of investing in Peru’s health care systems and long-term development, mainly through the U.S. Agency for International Development (USAID).
Ongoing U.S. Government-funded programs and partners are also adapting activities to respond to this unprecedented crisis. Over the last 20 years, U.S. assistance to Peru totals more than $3.5 billion, including $265 million in the health sector. Emergency assistance comes from the U.S. Agency for International Development (USAID), the Department of Defense Humanitarian Assistance Program, and the Department of State’s Emergency Refugee and Migration Assistance fund.
Mitigate the adverse social and economic impacts of COVID-19 on vulnerable populations in Perú, particularly within indigenous communities in the Peruvian Amazon is critical. USAID and the Alliance support the Government of Perú to adequately respond to COVID- 19 crisis, particularly in under-resourced Amazon regions of Perú.
This activity seeks to reduce the impacts of the disease through an approach that integrates communication for behavior change / social change and the active participation of the organized community.
Likewise, orientation, counseling and emotional containment services will be provided to the most vulnerable populations, and economic recovery initiatives will be supported for families living in communities in priority geographic areas, taking into account their needs and idiosyncrasies.
USAID partnership with Socios en Salud, the Peruvian affiliate of the U.S. non-profit organization Partners in Health, responds to COVID-19 in Peru.
This Alliance supports aggressive contact tracing, community mobilization, and systematic screening and isolation to prevent community spread of COVID-19. The $8,261,090 investment from USAID mobilizes additional $1 million from Boston-based Partners in Health.
As part of the U.S. Government’s commitment to global frontline efforts to get shots into arms and save lives around the world, U.S. Agency for International Development (USAID) Administrator Samantha Power has announced the U.S. Government’s Initiative for Global Vaccine Access, or Global VAX for short.
This fact sheet provides updates on USAID's COVID-19 response in the Sub-Saharan Africa region.
Comment
Make a general inquiry or suggest an improvement.